Posterior reversible encephalopathy syndrome in systemic lupus erythematosus

Nephrology Dialysis Transplantation

Volumn 23, Issue 2, 2008, Pages 757-763

  El Karoui, Khalil ^a   Le Quintrec, Moglie ^a   Dekeyser, Eric ^a   Servais, Aude ^a   Hummel, Aurélie ^a   Fadel, Fouad ^a   Fakhouri, Fadi ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Posterior reversible encephalopathy; Systemic lupus erythematosus

Indexed keywords

ACEBUTOLOL; AMLODIPINE; CLOBAZAM; CLONAZEPAM; CORTICOSTEROID; CYCLOPHOSPHAMIDE; FUROSEMIDE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICARDIPINE; PREDNISONE; RAMIPRIL; RITUXIMAB; URAPIDIL; VALPROIC ACID;

ADOLESCENT; ADULT; ARTICLE; BRAIN DISEASE; CASE REPORT; CEREBRAL BLINDNESS; CEREBROSPINAL FLUID; DIFFUSION WEIGHTED IMAGING; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; KIDNEY BIOPSY; LABORATORY TEST; LUPUS ERYTHEMATOSUS NEPHRITIS; MIOSIS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PERICARDITIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TONIC CLONIC SEIZURE; VASCULITIS;

ADOLESCENT; ADULT; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME;

EID: 44449128108     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm811     Document Type: Article

References (38)

1. The American College of Rheumatology. Nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599-608
2. Kur JK, Esdaile JM. Posterior reversible encephalopathy syndrome: an underrecognized manifestation of systemic lupus erythematosus. J Rheumatol 2006; 33: 2178-2183
3. Primavera A, Audenino D, Mavilio N et al. Reversible posterior leucoencephalopathy syndrome in systemic lupus and vasculitis. Ann Rheum Dis 2001; 60: 534-537
4. Hinchey J, Chaves C, Appignani B et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334: 494-500
5. Mavragani CP, Vlachoyiannopoulos PG, Kosmas N et al. A case of reversible posterior leucoencephalopathy syndrome after rituximab infusion. Rheumatology (Oxford) 2004; 43: 1450-1451
6. Thaipisuttikul I, Phanthumchinda K. Recurrent reversible posterior leukoencephalopathy in a patient with systemic lupus erythematosus. J Neurol 2005; 252: 230-231
7. Yong PF, Hamour SM, Burns A. Reversible posterior leukoencephalopathy in a patient with systemic sclerosis/systemic lupus erythematosus overlap syndrome. Nephrol Dial Transplant 2003; 18: 2660-2662
8. Shin KC, Choi HJ, Bae YD et al. Reversible posterior leukoencephalopathy syndrome in systemic lupus erythematosus with thrombocytopenia treated with cyclosporine. J Clin Rheumatol 2005; 11: 164-166
9. Ozyurek H, Oguz G, Ozen S et al. Reversible posterior leukoencephalopathy syndrome: report of three cases. J Child Neurol 2005; 20: 990-993
10. Magnano MD, Bush TM, Herrera I et al. Reversible posterior leukoencephalopathy in patients with systemic lupus erythematosus 2006; Semin Arthritis Rheum. 35: 396-402
11. Prasad N, Gulati S, Gupta RK et al. Is reversible posterior leukoencephalopathy with severe hypertension completely reversible in all patients? Pediatr Nephrol 2003; 18: 1161-1166
12. Lateef A, Lim AY Case reports of transient loss of vision and systemic lupus erythematosus. Ann Acad Med Singapore 2007; 36: 146-149
13. Matsushita K, Ozaki A, Inoue H et al. 2006 Stevens-Johnson syndrome induced by mizoribine in a patient with systemic lupus erythematosus. Mod Rheumatol 2006; 16: 113-116
14. Mukherjee P, McKinstry RC Reversible posterior leukoencephalopathy syndrome: evaluation with diffusion-tensor MR imaging. Radiology 2001; 219: 756-765
15. Bell CL, Partington C, Robbins M et al. Magnetic resonance imaging of central nervous system lesions in patients with lupus erythematosus. Correlation with clinical remission and antineurofilament and anticardiolipin antibody titers. Arthritis Rheum 1991; 34: 432-441
16. Cassano G, Gongora V, Zunino A et al. Reversible posterior leukoencephalopathy in systemic lupus erythematosuswith thrombotic thrombocytopenic purpura. J Clin Rheumatol 2007; 13: 55-57
17. Min L, Zwerling J, Ocava LC et al. Reversible posterior leukoencephalopathy in connective tissue diseases. Semin Arthritis Rheum 2006; 35: 388-395
18. Foocharoen C, Tiamkao S, Srinakarin J et al. Reversible posterior leukoencephalopathy caused by azathioprine in systemic lupus erythematosus. J Med Assoc Thai 2007; 89: 1029-1032
19. Casey SO, Sampaio RC, Michel E et al. Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol 2000; 21: 1199-1206
20. Stott VL, Hurrell MA, Anderson TJ. Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed. Intern Med J 2005; 35: 83-90
21. Brubaker LM, Smith JK, Lee YZ et al. Hemodynamic and permeability changes in posterior reversible encephalopathy syndrome measured by dynamic susceptibility perfusion-weighted MR imaging. AJNR Am J Neuroradiol 2005; 26: 825-830
22. Covarrubias DJ, Luetmer PH, Campeau NG. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol 2002; 23: 1038-1048
23. Mirza A Posterior reversible encephalopathy syndrome: a variant of hypertensive encephalopathy. J Clin Neurosci 2006; 13: 590-595
24. Lamy C, Oppenheim C, Meder JF et al. Neuroimaging in posterior reversible encephalopathy syndrome. J Neuroimaging 2004; 14: 89-96
25. Servillo G, Bifulco F, De Robertis E et al. Posterior reversible encephalopathy syndrome in intensive care medicine. Intensive Care Med 2006; 33: 230-236
26. Ito Y, Niwa H, Iida T et al. Post-transfusion reversible posterior leukoencephalopathy syndrome with cerebral vasoconstriction. Neurology 1997; 49: 1174-1175
27. Govindarajan R, Adusumilli J, Baxter DL et al. Reversible posterior leukoencephalopathy syndrome induced by RAF kinase inhibitor BAY 43 9006. J Clin Oncol 2006; 1: 24 e48
28. Ozcan C, Wong SJ, Hari P Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med 2006; 354: 980-982
29. Delanty N, Vaughan C, Frucht S et al. Erythropoietin-associated hypertensive posterior leukoencephalopathy. Neurology 1997; 49: 686-689
30. Kastrup O, Maschke M, Wanke I et al. Posterior reversible encephalopathy syndrome due to severe hypercalcemia. J Neurol 2002; 249: 1563-1566
31. Ahn KJ, You WJ, Jeong SL et al. Atypical manifestations of reversible posterior leukoencephalopathy syndrome: findings on diffusion imaging and ADC mapping. Neuroradiology 2004; 46: 978-983
32. Ay H, Buonanno FS, Schaefer PW et al. Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. Neurology 1998; 51: 1369-1376
33. Pande AR, Ando K, Ishikura R et al. Clinicoradiological factors influencing the reversibility of posterior reversible encephalopathy syndrome: a multicenter study. Radiat Med 2006; 24: 659-668
34. Garg RK Posterior leukoencephalopathy syndrome. Postgrad Med J 2001; 77: 24-28
35. Servillo G, Striano P, Striano S et al. Posterior reversible encephalopathy syndrome (PRES) in critically ill obstetric patients. Intensive Care Med 2003; 29: 2323-2326
36. Limdi NA, Shimpi AV, Faught E et al. Efficacy of rapid IV administration of valproic acid for status epilepticus. Neurology 2005; 64: 353-355
37. Misra UK, Kalita J, Patel R. Sodium valproate vs phenytoin in status epilepticus: a pilot study. Neurology 2006; 67: 340-342
38. Antunes NL, Small TN, George D et al. Posterior leukoencephalopathy syndrome may not be reversible. Pediatr Neurol 1999; 20: 241